Cold Chain Product and Service Directory | Pharmaceutical Outsourcing

Evonik Invests $109 Million in Vancouver Lipid Drug Facility
Tuesday, September 01, 2026
Evonik will invest more than 150 million Canadian dollars, or about $109 million, to build a new good manufacturing practice drug-product facility in Vancouver, Canada, expanding its capacity for lipid-based drug delivery products including vaccines, therapeutics and other advanced medicines. read more
Andelyn to Scale Manufacturing for Genprex Diabetes Gene Therapy
Tuesday, September 01, 2026
Andelyn Biosciences has been selected by Genprex Inc. to support manufacturing scale-up for an adeno-associated virus-based gene therapy program being developed for Type 1 and Type 2 diabetes. read more
Samsung Biologics Launches $1.83 Billion Tender Offer for PolyPeptide
Tuesday, September 01, 2026
Samsung Biologics has published the formal prospectus for its planned acquisition of PolyPeptide Group AG, offering about $55.70 in cash per share in a transaction that values the Swiss peptide manufacturer’s equity at approximately $1.83 billion. read more
CPHI Milan Pharma Awards 2026 Finalists Announced
Tuesday, September 01, 2026
Informa Markets has announced the finalists for the CPHI Pharma Awards 2026, recognizing outstanding achievements across companies and individuals pushing the boundaries of science and technology to advance global healthcare. read more
When commercialization doesn't follow a standard playbook
Monday, August 31, 2026
Low-volume launches. Complex combination products. Market-specific requirements. Unpredictable demand. Commercialization challenges are different for every program, yet many outsourcing models are built for standardization, not flexibility.
Discover how Ensera helps pharmaceutical companies ... read more